Table 2 Numbers and percentages of patients treated at each course

From: Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

 

Course number

 

1

2

3

4

5

6

C3 (N=150)

150

136

117

—

—

—

Per cent

100

91

78

—

—

—

C6 (N=147)

143

134

116

99

88

79

Per cent

97

91

79

67

60

54

  1. C3 patients were randomised to receive three courses, while C6 patients were randomised to receive six courses of chemotherapy
Back to article page